BridgeBio Pharma, Inc.

8-K Other events Jul 22, 2026 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Jul 2, 2026 8-K Director or officer change; Shareholder vote results Jun 26, 2026 8-K Other events May 27, 2026 8-K Other events May 13, 2026 8-K Entered a material agreement; Terminated a material agreement May 8, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release); Other events May 7, 2026 8-K Other events Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Other events Feb 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Jan 21, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Other events Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Other events Oct 27, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jul 2, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 23, 2025 10-Q Quarter ended 2025-03-31 Apr 29, 2025 8-K Results of operations (earnings release) Apr 29, 2025 8-K Director or officer change; Regulation FD disclosure Mar 17, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Other events Feb 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 20, 2025 8-K Results of operations (earnings release) Feb 20, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 13, 2025 8-K Other events Nov 25, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Sep 11, 2024 8-K Entered a material agreement Aug 21, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change; Regulation FD disclosure Jul 23, 2024 8-K Shareholder vote results Jun 24, 2024 8-K Other events Jun 6, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024